These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32260091)

  • 1. Antibodies, Nanobodies, or Aptamers-Which Is Best for Deciphering the Proteomes of Non-Model Species?
    Dhar P; Samarasinghe RM; Shigdar S
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond antibodies: new affinity reagents to unlock the proteome.
    Lollo B; Steele F; Gold L
    Proteomics; 2014 Mar; 14(6):638-44. PubMed ID: 24395722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamers and the next generation of diagnostic reagents.
    Thiviyanathan V; Gorenstein DG
    Proteomics Clin Appl; 2012 Dec; 6(11-12):563-73. PubMed ID: 23090891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A screening method for DNA aptamers that bind to a specific, unidentified protein in tissue samples.
    Noma T; Ikebukuro K; Sode K; Ohkubo T; Sakasegawa Y; Hachiya N; Kaneko K
    Biotechnol Lett; 2006 Sep; 28(17):1377-81. PubMed ID: 16819584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical and biological issues relevant to cell typing with aptamers.
    Li N; Ebright JN; Stovall GM; Chen X; Nguyen HH; Singh A; Syrett A; Ellington AD
    J Proteome Res; 2009 May; 8(5):2438-48. PubMed ID: 19271740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamers and nanobodies as alternatives to antibodies for ligand-targeted drug delivery in cancer.
    Sanjanwala D; Patravale V
    Drug Discov Today; 2023 May; 28(5):103550. PubMed ID: 36906220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in binder identification and characterisation: the case of oligonucleotide aptamers.
    Taouji S; Dausse E; Evadé L; Di Primo C; Toulmé JJ; Chevet E
    N Biotechnol; 2012 Jun; 29(5):550-4. PubMed ID: 22178698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for surveying the proteome using affinity proteomics and mass spectrometry.
    Wingren C; James P; Borrebaeck CA
    Proteomics; 2009 Mar; 9(6):1511-7. PubMed ID: 19235165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of proteome-wide binding reagents for research and diagnostics.
    Taussig MJ; Schmidt R; Cook EA; Stoevesandt O
    Proteomics Clin Appl; 2013 Dec; 7(11-12):756-66. PubMed ID: 24178846
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Hammarén MM; Luukinen H; Sillanpää A; Remans K; Lapouge K; Custódio T; Löw C; Myllymäki H; Montonen T; Seeger M; Robertson J; Nyman TA; Savijoki K; Parikka M
    mSystems; 2023 Jun; 8(3):e0107322. PubMed ID: 37184670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life's simple measures: unlocking the proteome.
    Brody E; Gold L; Mehan M; Ostroff R; Rohloff J; Walker J; Zichi D
    J Mol Biol; 2012 Oct; 422(5):595-606. PubMed ID: 22721953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteomics uncovers the signature of natural selection acting on the ejaculate proteomes of two cricket species isolated by postmating, prezygotic phenotypes.
    Marshall JL; Huestis DL; Garcia C; Hiromasa Y; Wheeler S; Noh S; Tomich JM; Howard DJ
    Mol Biol Evol; 2011 Jan; 28(1):423-35. PubMed ID: 20805188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nanobody toolbox to investigate localisation and dynamics of
    Loreau V; Rees R; Chan EH; Taxer W; Gregor K; Mußil B; Pitaval C; Luis NM; Mangeol P; Schnorrer F; Görlich D
    Elife; 2023 Jan; 12():. PubMed ID: 36645120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping cytoskeletal protein function in cells by means of nanobodies.
    Van Audenhove I; Van Impe K; Ruano-Gallego D; De Clercq S; De Muynck K; Vanloo B; Verstraete H; Fernández LÁ; Gettemans J
    Cytoskeleton (Hoboken); 2013 Oct; 70(10):604-22. PubMed ID: 23818458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and processing of aptamer microarrays.
    Collett JR; Cho EJ; Ellington AD
    Methods; 2005 Sep; 37(1):4-15. PubMed ID: 16199170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity proteomics: the role of specific binding reagents in human proteome analysis.
    Stoevesandt O; Taussig MJ
    Expert Rev Proteomics; 2012 Aug; 9(4):401-14. PubMed ID: 22967077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modern affinity reagents: Recombinant antibodies and aptamers.
    Groff K; Brown J; Clippinger AJ
    Biotechnol Adv; 2015 Dec; 33(8):1787-98. PubMed ID: 26482034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arabidopsis thaliana as a model organism for plant proteome research.
    Wienkoop S; Baginsky S; Weckwerth W
    J Proteomics; 2010 Oct; 73(11):2239-48. PubMed ID: 20692386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabbit antibody detection with RNA aptamers.
    Yoshida Y; Sakai N; Masuda H; Furuichi M; Nishikawa F; Nishikawa S; Mizuno H; Waga I
    Anal Biochem; 2008 Apr; 375(2):217-22. PubMed ID: 18252191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamers for nanobodies: A nontoxic alternative to toxic ochratoxin A in immunoassays.
    Hou Y; Liu X; Li Y; Hou J; Liu H; Wu Q; Liu J
    Biosens Bioelectron; 2024 Mar; 248():115995. PubMed ID: 38176255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.